Lyophilized synthetic peptide supplied in a sealed sterile vial. Characterized by HPLC and mass spectrometry. For in-vitro laboratory research use only. Not for human or veterinary use.

Research Use Only

Sold strictly as a lyophilized analytical reference standard for in-vitro laboratory research by qualified professionals. Not for use in any living organism. Not a drug, food, cosmetic, or dietary supplement. No medical, therapeutic, diagnostic, or health claims are made. No dosing or administration guidance is provided.

Research Overview

The 20 mg size of the triple-receptor metabolic peptide, for studies that need more material.

Retatrutide acts on the GLP-1, GIP, and glucagon receptors — three pathways tied closely to metabolism. Researchers have studied appetite-related signaling, blood sugar control, and fat and energy metabolism. The 20 mg vial is a popular choice where a larger amount of reference material is required.

What studies have looked at

Appetite and satiety signaling
Glucose handling in research models
Fat and energy metabolism markers
Larger-volume or longer study designs

Research Information

The information above is provided for educational and research reference purposes only. These products are intended for laboratory research use only and are not approved for human consumption. Statements on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Certificate of Analysis

Every batch of Retatrutide is independently characterized by HPLC and mass spectrometry. The full COA — including chromatogram, mass spec data, net purity, and net content verification — is available on request for the lot you receive.

View Certificates of Analysis Request Batch COA